| Net Cash Provided by (Used in) Operating Activities |
$-415,765 |
USD |
15% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$-87,600 |
USD |
41% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
4,572,713 |
shares |
64% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,930,053 |
USD |
35% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$7,507,522 |
USD |
6.4% |
Q2 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$7,675,177 |
USD |
5.7% |
Q2 2024 |
FY 2024 |
| Depreciation |
$6,337 |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$182,343 |
USD |
0% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$7,202,000 |
USD |
14% |
Q2 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$44,260,884 |
USD |
7.8% |
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
$118,275 |
USD |
-22.37% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,074,000 |
USD |
|
Q2 2024 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$13,875 |
USD |
-77.8% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |